Identification of Elongation Factor G as the Conserved Cellular Target of Argyrin B
0301 basic medicine
Burkholderia
Science
Molecular Sequence Data
Microbial Sensitivity Tests
Saccharomyces cerevisiae
Crystallography, X-Ray
Mitochondrial Proteins
03 medical and health sciences
Cell Line, Tumor
Animals
Humans
Amino Acid Sequence
Conserved Sequence
Mammals
Sequence Homology, Amino Acid
Q
R
Peptide Elongation Factor G
Pseudomonas aeruginosa
Medicine
Mutant Proteins
Oligopeptides
Allosteric Site
Research Article
Protein Binding
DOI:
10.1371/journal.pone.0042657
Publication Date:
2012-09-10T21:08:04Z
AUTHORS (29)
ABSTRACT
Argyrins, produced by myxobacteria and actinomycetes, are cyclic octapeptides with antibacterial and antitumor activity. Here, we identify elongation factor G (EF-G) as the cellular target of argyrin B in bacteria, via resistant mutant selection and whole genome sequencing, biophysical binding studies and crystallography. Argyrin B binds a novel allosteric pocket in EF-G, distinct from the known EF-G inhibitor antibiotic fusidic acid, revealing a new mode of protein synthesis inhibition. In eukaryotic cells, argyrin B was found to target mitochondrial elongation factor G1 (EF-G1), the closest homologue of bacterial EF-G. By blocking mitochondrial translation, argyrin B depletes electron transport components and inhibits the growth of yeast and tumor cells. Further supporting direct inhibition of EF-G1, expression of an argyrin B-binding deficient EF-G1 L693Q variant partially rescued argyrin B-sensitivity in tumor cells. In summary, we show that argyrin B is an antibacterial and cytotoxic agent that inhibits the evolutionarily conserved target EF-G, blocking protein synthesis in bacteria and mitochondrial translation in yeast and mammalian cells.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (45)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....